Humanetics Grants Exclusive License to iSatori

CHANHASSEN, Minn.--Humanetics Corp. (www.humaneticscorp.com)granted an exclusive worldwide license to iSatori Global Technologies to createand market products containing Humanetics patent-pending technology forincreased whole body creatine retention. The technology is based on combiningcreatine with specific doses of Inzitol, Humanetics proprietary d-pinitolingredient that acts as a natural insulin mediator.

iSatori is introducing the technology in its product Meta-CEL - MuscleAugmentation System. The product was developed in conjunction with nutritionaland exercise biochemist Anthony Almada, who also conducted the studies usingInzitol.